Cargando…

Relationship Between T-Cell Exosomes and Cellular Subsets in SLE According to Type I IFN-Signaling

Objective: To quantify the levels of circulating exosomes derived from T-cells and monocytes and their possible associations with leukocyte subpopulations and cytokine milieu in Systemic Lupus Erythematosus (SLE). Methods: Total circulating exosomes (CD9(+)-Ex) and those derived from T-cells (CD3(+)...

Descripción completa

Detalles Bibliográficos
Autores principales:	López, Patricia, Rodríguez-Carrio, Javier, Caminal-Montero, Luis, Suárez, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734125/ https://www.ncbi.nlm.nih.gov/pubmed/33330567 http://dx.doi.org/10.3389/fmed.2020.604098

Ejemplares similares

A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients
por: López, Patricia, et al.
Publicado: (2016)

Influence of Atg5 Mutation in SLE Depends on Functional IL-10 Genotype
por: López, Patricia, et al.
Publicado: (2013)

IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)
por: Oke, Vilija, et al.
Publicado: (2017)

IFN-γ, should not be ignored in SLE
por: Liu, Wenping, et al.
Publicado: (2022)

Novel Immune Cell Subsets Exhibit Different Associations With Vascular Outcomes in Chronic Kidney Disease Patients—Identifying Potential Biomarkers
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2021)

Anti-High-Density Lipoprotein Antibodies and Antioxidant Dysfunction in Immune-Driven Diseases
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2018)

IFNα Inducible Models of Murine SLE
por: Liu, Zheng, et al.
Publicado: (2013)

IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2019)

IFNα Serum Levels Are Associated with Endothelial Progenitor Cells Imbalance and Disease Features in Rheumatoid Arthritis Patients
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2014)

IL-10 and TNFα Genotypes in SLE
por: López, Patricia, et al.
Publicado: (2010)

The effect of prolactin on immune cell subsets involved in SLE pathogenesis
por: Legorreta-Haquet, Maria Victoria, et al.
Publicado: (2022)

Activity Disease in SLE Patients Affected IFN-γ in the IGRA Results
por: Maharani, Winni, et al.
Publicado: (2020)

Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort
por: Wahadat, M Javad, et al.
Publicado: (2022)

SLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis
por: Itotagawa, Eri, et al.
Publicado: (2022)

Uncoupling interferons and the interferon signature explain clinical and transcriptional subsets in SLE
por: Gómez-Bañuelos, Eduardo, et al.
Publicado: (2023)

A subset of low density granulocytes is associated with vascular calcification in chronic kidney disease patients
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2019)

IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients
por: Sciascia, Savino, et al.
Publicado: (2019)

Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE
por: Burns, Marie, et al.
Publicado: (2021)

The Role of Long Non-coding RNAs in the Pathogenesis of RA, SLE, and SS
por: Gao, Yunzhen, et al.
Publicado: (2018)

CD8+ T-Cells in Juvenile-Onset SLE: From Pathogenesis to Comorbidities
por: Ciurtin, Coziana, et al.
Publicado: (2022)

Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2018)

Factors Associated With Use of Telemedicine for Follow-Up of SLE in the COVID-19 Outbreak
por: So, Ho, et al.
Publicado: (2021)

The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE
por: Hagberg, Niklas, et al.
Publicado: (2018)

Conventional DCs from Male and Female Lupus-Prone B6.NZM Sle1/Sle2/Sle3 Mice Express an IFN Signature and Have a Higher Immunometabolism That Are Enhanced by Estrogen
por: Lee, Michael H., et al.
Publicado: (2018)

Cardiac Fibrosis: Cellular Effectors, Molecular Pathways, and Exosomal Roles
por: Jiang, Wenyang, et al.
Publicado: (2021)

Case Report: Kidney Transplantation in a Patient With Acquired Agammaglobulinemia and SLE. Issues and Challenges
por: Pavlakou, Paraskevi, et al.
Publicado: (2021)

An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management
por: Ameer, Muhammad Atif, et al.
Publicado: (2022)

Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs
por: López, Patricia, et al.
Publicado: (2006)

Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases
por: Flint, Shaun M, et al.
Publicado: (2016)

Cellular Crosstalk in the Vascular Wall Microenvironment: The Role of Exosomes in Vascular Calcification
por: Wu, Yun-Yun, et al.
Publicado: (2022)

ZNF395 Is an Activator of a Subset of IFN-Stimulated Genes
por: Schroeder, Linda, et al.
Publicado: (2017)

Mild Encephalitis/Encephalopathy with Reversible Splenial Lesions in SLE
por: Ohkubo, Naoaki, et al.
Publicado: (2020)

Editorial: Global excellence in rheumatology: Europe
por: Alunno, Alessia, et al.
Publicado: (2023)

Organ system-involvement in SLE and relationship with demographic factors, disease duration and health-related quality of life in childhood SLE
por: Moorthy, Lakshmi N, et al.
Publicado: (2012)

Therapeutic Strategies for SLE Involving Cytokines: Mechanism-Oriented Therapies Especially IFN-γ Targeting Gene Therapy
por: Hayashi, Toshiharu
Publicado: (2010)

NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-α production in patients with SLE
por: Georgakis, Spiros, et al.
Publicado: (2021)

Chinese SLE Treatment and Research Group Registry (CSTAR) XIV: the subjective well-being of patients with systemic lupus erythematosus
por: Shi, Yue, et al.
Publicado: (2022)

The relationship between the clearance of HBsAg and the remodeling of B cell subsets in CHB patients treated with Peg-IFN-α
por: Wu, Ze-Qian, et al.
Publicado: (2021)

Non-Cirrhotic Portal Hypertension in Systemic Lupus Erythematosus
por: Suárez-Díaz, Silvia, et al.
Publicado: (2023)

Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatment in patients with SLE
por: Struemper, Herbert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jtp9s4cb0d477a0qtm9rs0f4se